Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin (2011)
- Authors:
- Cerda, Alvaro
- Genvigir, Fabiana Dalla Vecchia
- Willrich, Maria Alice Vieira
- Arazi, Simone Sorkin
- Bernik, Marcia Martins Silveira
- Dórea, Egidio Lima
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Faludi, André Arpad - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; DOREA, EGIDIO LIMA - HU
- Unidades: FCF; HU
- DOI: 10.1186/1476-511X-10-206
- Subjects: APOLIPOPROTEÍNAS; HIPERCOLESTEROLEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Lipids in Health and Disease
- ISSN: 1476-511X
- Volume/Número/Paginação/Ano: v. 10, art. 206, p. 1-11, 2011
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CERDA, Alvaro et al. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, v. 10, p. 1-11, 2011Tradução . . Disponível em: https://doi.org/10.1186/1476-511X-10-206. Acesso em: 01 abr. 2026. -
APA
Cerda, A., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Bernik, M. M. S., Dórea, E. L., et al. (2011). Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. Lipids in Health and Disease, 10, 1-11. doi:10.1186/1476-511X-10-206 -
NLM
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1186/1476-511X-10-206 -
Vancouver
Cerda A, Genvigir FDV, Willrich MAV, Arazi SS, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin [Internet]. Lipids in Health and Disease. 2011 ; 10 1-11.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1186/1476-511X-10-206 - Leptin receptor gene polymorphisms are associated with adiposity and metabolic alterations in Brazilian individuals
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
